Search Browse Earnings

Verastem, Inc. — SlamSEC

Verastem, Inc.

Nasdaq:VSTM

Pharmaceutical Preparations·NEEDHAM, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$2.6M

-97.1% YoY

FY 2024

Adj. EBITDA

-$91.7M

-3530.7% margin

FY 2025

Net Income

-$87.4M

-3365.4% margin

FY 2025

EPS (Diluted)

-$3.96

FY 2025

Stock Price

$6.29

-1.5%

2026-03-09

52W Range

$4.01 – $11.24

P/E Ratio

-1.6x

Market Cap

$552.9M

Cash

$88.8M

FY 2025

Total Debt

$14.8M

FY 2017

Net Cash

$74.0M

FY 2017

Enterprise Value

$478.9M

Debt / EBITDA

0.8x

FY 2024

EV / EBITDA

-5.2x

Employees

—

CEO

Paterson Dan

CFO

Calkins Daniel